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Abstract
Background: Pediatric cataract is an important cause of blindness and visual
impairment in children. A large proportion of pediatric cataracts are inherited, and
many genes have been described for this heterogeneous Mendelian disease. Sur-
veys of schools for the blind in Bhutan, Cambodia, and Sri Lanka have identified
many children with this condition and we aimed to identify the genetic causes of
inherited cataract in these populations.
Methods: We screened, in parallel, 51 causative genes for inherited cataracts in
33 probands by Ampliseq enrichment and sequencing on an Ion Torrent PGM.
Rare novel protein coding variants were assessed for segregation in family mem-
bers, where possible, by Sanger sequencing.
Results: We identified 24 rare (frequency <1% in public databases) or novel protein
coding variants in 12 probands and confirmed segregation of variants with disease
in the extended family where possible. Of these, six are predicted to be the cause of
disease in the patient, with four other variants also highly likely to be pathogenic.
Conclusion: This study found that 20%–30% of patients in these countries have a
mutation in a known cataract causing gene, which is considerably lower than the
60%–70% reported in Caucasian cohorts. This suggests that additional cataract
genes remain to be discovered in this cohort of Asian pediatric cataract patients.
†These authors contributed equally to this work.
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1 | INTRODUCTION
Pediatric cataract (including congenital cataract) is an opacity
of the ocular lens that is present at birth (congenital) or devel-
ops during childhood. Prevalence estimates range from 0.33 to
22.7 per 10,000 (Sheeladevi, Lawrenson, Fielder, & Suttle,
2016) live births in populations across the world. It was previ-
ously thought that prevalence was around 10 times greater in
low-income economies than high-income countries (Foster,
Gilbert, & Rahi, 1997), but more recent reviews suggest that
this is not the case with high prevalence reported in many
higher income countries (Sheeladevi et al., 2016). Nonethe-
less, cataract is an important cause of childhood blindness
globally and is one of the preventable and treatable conditions
targeted by Vision 2020 programs (Gilbert & Foster, 2001).
Around 25% of pediatric cataract is inherited (Shiels &
Hejtmancik, 2007) and over 100 genes have been reported
for isolated pediatric cataract, with hundreds more for syn-
dromic cataract (Shiels, Bennett, & Hejtmancik, 2010). Cat-
aract-causing genes include structural proteins of the
crystalline lens as well as transport molecules, signaling pro-
teins, and transcription factors. Analysis of panels of catar-
act-causing genes in patients with inherited cataract detect
mutations in 60%–70% of patients (Gillespie et al., 2014;
Javadiyan et al., 2017; Ma et al., 2016), but these studies
have been undertaken in cohorts of patients predominantly
of European descent. Mutations in these same genes have
been reported in patients from all over the world; however,
large-scale gene screening has not yet been undertaken in
patients with pediatric cataract from developing countries.
Recently, surveys to document causes of childhood blind-
ness have been undertaken in Bhutan (Farmer et al., 2015),
Cambodia (Sia et al., 2010), and Sri Lanka (Gao et al., 2011).
These studies identified many children in attendance at schools
for the blind in these countries, with cataract as the underlying
cause of their visual impairment. We investigated the genetic
causes of cataract in children with suspected or known inher-
ited cataract through screening of 51 genes known to cause
this disease, using the same methodologies as applied to Aus-
tralian pediatric cataract patients (Javadiyan et al., 2017).
2 | MATERIALS AND METHODS
2.1 | Ethical compliance
Consent for each participant was obtained from parent,
guardian, or other authorized persons in the first language
of the patient or parent. The study was approved in
Australia by the Human Research Ethics Committees of the
University of Adelaide and Flinders University in South
Australia. In Bhutan, permission to visit schools was
granted by the respective ministries of Health in Bhutan.
Approval was also obtained from the Research Committees
at the National Referral Hospital, Thimphu, Bhutan. In
Cambodia, permission to visit schools was granted by the
Ministry of Health, Cambodia and approval was obtained
from the National Ethics Committee for Health Research in
Cambodia. In Sri Lanka, permission to visit the schools
was granted by each principal and ethics approval was
obtained from the Faculty of Medicine, University Of Per-
adenya Ethical Review Committee. The study adhered to
the tenets of the Declaration of Helsinki.
2.2 | Participant selection
Children under 16 years of age attending blind schools in
Bhutan (Farmer et al., 2015), Cambodia (Sia et al., 2010),
and Sri Lanka (Gao et al., 2011) underwent an ocular
examination and review of records as part of audits of the
causes of childhood blindness in each community as
described previously (Farmer et al., 2015; Gao et al., 2011;
Sia et al., 2010). While all children were examined at the
time of recruitment, it was not possible to access historical
medical records to determine age of onset, or to interview
the family for a detailed history. The recruitment of addi-
tional family members was only possible if the family
decided to attend the school on the day of the survey.
Patients were included in this analysis if they were
observed to have bilateral pediatric (or congenital) cataract,
with or without other ocular or systemic features. Patients
with aniridia were excluded, even if cataract was also pre-
sent. Where possible, additional affected and unaffected
family members were also examined and recruited. Saliva
was collected from each participant in the DNA saliva col-
lection kit (Oragene DNA saliva collection kit) and
extracted using prepIT L2P (DNA Genotek Inc., Ottawa,
ON, Canada).
2.3 | Screening of cataract genes
Genes known to cause pediatric cataract in human or
mouse were selected from the literature and the complete
list is available in Table S1. Fifty-one genes known to
cause pediatric cataract were sequenced as described previ-
ously, (Javadiyan et al., 2017), using identical sequencing,
variant filtering, and functional prediction methods to allow
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direct comparison between studies. PCR primers to amplify
coding, 30- and 50- untranslated regions of the 51 genes
were designed with the Ion AmpliSeq Designer tool v1.22
(Life Technologies, www.ampliseq.com) and used to pre-
pare amplicon-based sequencing libraries with the Ion
AmpliSeq library kit version 2.0. Sequencing was per-
formed on an Ion Torrent PGM using The Ion PGM
Sequencing 200 Kit v2 and an Ion 318 chip (Life Tech-
nologies). The final assay design consisted of a total of
1,216 amplicons ranging from 125 to 225 bp, covering
94.3% of the 154.1 kb target sequence.
Sequence alignment, variant calling, and annotation were
performed as described previously (Siggs et al., 2017).
Briefly, reads were aligned to the human genome reference
sequence 19 (hg19) and variants called using the Torrent
Suite v3.6 tools and annotated with Ion Reporter v4.0.
Variants were prioritized for validation and further ana-
lyzed if they were predicted to be protein-changing, and
were absent or rare with minor allele frequency
(MAF) <1% in dbSNP137 (https://www.ncbi.nlm.nih.gov/
SNP/), the Exome Aggregation Consortium (ExAC) (http://
exac.broadinstitute.org/), and gnomAD (http://gnomad.b
roadinstitute.org/). In addition, identified variants were
compared with an in-house list of common sequencing
errors previously detected with this gene panel (Javadiyan
et al., 2017).
2.4 | Confirmation of variants
Sanger sequencing was used to confirm the presence of
variants meeting the filtering criteria and to assess segrega-
tion of mutations in families. Forward and reverse primer
sequences were designed using Primer3 (Koressaar &
Remm, 2007; Untergasser et al., 2012). PCR and sequenc-
ing was conducted as described previously (Siggs et al.,
2017). Sequence chromatograms of affected and unaffected
individuals were compared to each other and the reference
sequence (see Table S1 for GenBank accession numbers)
using Sequencher v.5 (GeneCodes Corporation, Ann Arbor,
MI, USA).
Two detected variants in GALK1 in proband WW1
could not be assessed by Sanger sequencing due to difficul-
ties with primer design for fragments suitable for capillary
sequencing. These two variants were confirmed using
Sequenom iPLEX GOLD chemistry on an Autoflex Mass
Spectrometer at the Australian Genome Research Facility,
Brisbane, Australia.
2.5 | Functional predictions
Each confirmed segregating novel mutation was assessed
for a potential functional effect on the predicted protein
sequence using SIFT (Kumar, Henikoff, & Ng, 2009)
(http://sift.jcvi.org/) and the HumDiv model of Polyphen-2
(Adzhubei et al., 2010) (version 2.2.2) (http://genetics.bwh.
harvard.edu.ezproxy.utas.edu.au/pph2/). The conservation
of each altered amino acid was calculated using PhyloP as
implemented in Mutation Taster (http://www.mutationtaste
r.org/) and available through the University of California
Santa Cruz (UCSC) genome browser. PhyloP values
between 14 and +6 indicate conservation at individual
nucleotides, ignoring the effects of neighboring nucleotides.
Amino acid conservation across species was visualized
using the Mutation Taster website. Variants were also
assessed against the recommendations of the American
College of Medical Genetics and Genomics and the Associ-
ation for Molecular Pathology (Richards et al., 2015).
All variants reported in this study have been submitted
to the ClinVar database (https://www.ncbi.nlm.nih.gov/clin
var/; ClinVar accessions 3267773).
3 | RESULTS
Thirty-three probands with pediatric cataract were screened
for mutations in the 51 reported cataract-causing genes.
The mean number of mapped reads per sample was
1,259,305 with 86% of reads on target. A mean of 892
reads was achieved per amplicon, with a coverage unifor-
mity of 89%. Of all the amplicons, 93% and 88% were cov-
ered at least 20- and 100-fold, respectively. The average
coverage per gene is shown in Figure 1. Of the 1,216
amplicons, 27 amplicons (2%) across 15 genes were cov-
ered <20-fold (Figure S1).
A total of 4,844 variants were annotated with an aver-
age of 146 variants per individual. In total, 188 variants
were absent or rare (Minor Allele Frequency <1%) in pub-
licly referenced databases including ExAC which contains
4,327 individuals from East Asian and 8,256 individuals
from South Asian countries. Of the 188 variants, 90 were
nonsynonymous exonic variants. Sixty-five of these vari-
ants were removed due to their presence in our in-house
list of sequencing artifacts observed on the Ion Torrent
platform with this gene panel. Of the remaining 25 vari-
ants, 24 variants were confirmed by Sanger sequencing in
12 probands (Table 1) and one was a false positive. The
clinical phenotype observed in each proband is described
in Table 2.
3.1 | Bhutanese probands
Of the five probands recruited, three had variants in the
screened genes meeting the filtering criteria of rare and
protein coding (Table 1). A novel mutation was detected in
proband P1 in GJA8, c.839C>G, resulting in
p.(Pro280Arg). The proband was described as having
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congenital cataract with posterior capsule opacification and
has had surgery on both eyes (Table 2). The same mutation
was detected in the proband’s affected sister (Figure 2a)
but the parents were not available for analysis. This variant
is highly conserved and predicted to be damaging by both
SIFT and Polyphen-2 and is the most likely cause of dis-
ease in this family.
Variant c.766A>G resulting in p.(Arg256Gly) in GALE
was detected in patient E1 (Figure 2b). Along with pediatric
cataract, amblyopia and retinal dystrophy were reported in
this patient indicating the syndromic nature of the disease.
No other family members were available for assessment. The
variant is well conserved and is predicted to be damaging by
SIFT, but benign by Polyphen-2. It has been reported in
ExAC with a minor allele frequency of 0.000036 and
0.000025 in gnomAD. It cannot be said with certainty if this
variant is responsible for the disease in this proband.
Two variants in GALK1 were detected in proband
WW1, c.742C>T coding for p.(Arg248Trp) and c.485C>G,
coding for p.(Thr162Arg) (Figure 2c). Both of these vari-
ants were validated in the proband using MassArray geno-
typing due to technical infeasibility of Sanger sequencing.
Both the variants are predicted to be deleterious by SIFT
but only p.(Arg248Trp) is predicted to be damaging by
PolyPhen-2. However, these predictions do not take into
account the combined presence of these very rare variants
in the same patient with likely recessive inheritance. Nei-
ther variant was present in the proband’s unaffected brother
and together they likely account for autosomal recessive
inheritance of cataract in this proband.
3.2 | Cambodian probands
Fourteen probands from Cambodia were available for analy-
sis and rare coding variants were observed in four patients.
Patient BB16cat had a novel variant in the well-known
cataract gene, GJA8 (Figure 2d). Variant c.20T>C encod-
ing p.(Leu7Pro) is well conserved and predicted to be
pathogenic by multiple algorithms. No additional
phenotypic information was available for this patient and
family members were not available for genetic analysis,
however, this mutation is highly likely to be the cause of
the disease in this patient.
Patient PP50cat had a previously reported (Ma et al.,
2016) mutation in MIP c.97C>T encoding p.(Arg33Cys).
This well-conserved variant is predicted to be pathogenic
by both algorithms and segregates with cataract status in
the pedigree (Figure 2e). Variants were also detected in
COL4A1 and NSDHL (Table 1), but did not segregate with
cataract status in other family members, thus the MIP vari-
ant is the most likely cause of the disease in this family.
Proband SR11cat had a variant c.177G>C, p.(Arg59Ser)
in PAX6 (Figure 2f). The variant is novel, conserved, and
is predicted to be pathogenic by PolyPhen-2 but not SIFT.
No detailed phenotypic information or additional family
members were available for analysis. This variant may
account for the disease, but requires further confirmation.
SR12cat had variants in two genes, TDRD7 and
COL4A1. Both variants are also reported in ExAC at low
frequencies and neither segregated with the disease in the
family (Figure 2g). These variants are unlikely to be the
cause of the disease in this family.
3.3 | Sri Lankan probands
Of the 14 available patients, rare coding variants of these
genes were detected in five probands.
Proband PCC10-189 was homozygous for the
c.1153C>T variant coding for p.(Arg385Cys) in GCNT2.
The proband’s affected brother (individual II:1) was also
homozygous for this novel variant (Figure 2h). No DNA
was available from the parents, but neither was affected.
This mutation likely represents the cause of the autosomal
recessive cataract observed in these brothers.
The only variant detected in PCC01-34 is a rare mis-
sense mutation in HSF4 (Figure 2i). Although this gene is
well known to cause cataract, given that the variant is pre-
sent in the population, is in a poorly conserved region of
FIGURE 1 Average fold coverage of target genes sequenced from Ampliseq libraries in 33 Asian probands with pediatric cataract
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the protein and is predicted to be tolerated by both algo-
rithms, this variant is unlikely to be the cause of the dis-
ease in this patient. No additional family members were
available for segregation analysis.
Variants in three genes were detected in proband
PCC10-188, a rare variant in NHS and novel variants in
EPHA2 and GCNT2, both in the homozygous state (Fig-
ure 2j). The cataract was present at birth in the proband
and she had surgery in both eyes; however, no further
details were available. Due to the nature of the mutation,
the frameshift mutation in EPHA2 c.987_988insT, p.
(Ser330Phefs*51) is highly likely to be the cause of the
disease, although this is difficult to confirm in the absence
of additional family members. The mutation in GCNT2 in
PCC10-188 is the same novel homozygous mutation that
was found segregating in PCC-189 and his brother
(p.(Arg385Cys)). The possibility that this is a novel popu-
lation specific variant should be considered; however, it is
the most likely cause of disease detected in proband PCC-
189 and his brother.
Proband PCC01-97A displays rare coding variants in five
different cataract genes (Table 1). Three of the variants were
rare in the population (in AGK, TDRD7, and BFSP1) and two
(in PAX6 and CRYBB1) were novel (Figure 2k). Cataract in
this patient was present at birth and was described as syn-
dromic (with microphthalmos and pseudophakia). The
syndromic nature of the phenotype implicates PAX6, how-
ever, multiple other variants may be contributing to the pheno-
type in this patient with bioinformatic predictions suggesting
that all mutations except the one in PAX6 are likely to be
functional. Given that the variant in CRYBB1 is completely
novel and results in the deletion of a whole codon, it may be
considered the most likely causative variant. No other family
members were available for the study, limiting the ability to
interpret the findings of multiple variants.
Three variants were detected in two genes in PCC02-
105; two novel variants in CRYGD and one rare variant in
VIM (Table 1). The frameshift mutation in CRYGD,
c.477_477delC resulting in p.(Thr160Argfs*8) was the only
variant present in the proband and his three affected cou-
sins (Figure 2l) and as such is the probable cause of the
disease in this family.
4 | DISCUSSION
Thirty-three probands with pediatric cataract were recruited
during audits of the causes of childhood blindness in three
countries—Bhutan, Cambodia, and Sri Lanka. Rare, coding
variants were identified in 12 probands; however, these
variants are likely to explain the cause of the disease in
only six of these patients (P1 and WW1 from Bhutan;
TABLE 2 Observed phenotypes and potentially pathogenic rare coding variants detected in pediatric cataract genes in probands
Country Proband Causative gene(s) Phenotype
Age at
diagnosis
Age at
recruitment Sex
Surgery
Right
eye
Left
eye
Bhutan P1 GJA8 Congenital cataract with posterior capsule
opacification
Birth 16 F Yes Yes
E1 Possibly GALE Congenital cataract, amblyopia, retinal
dystrophy
Unknown 13 M Yes Yes
WW1 GALK1 Congenital cataract of unknown etiology Unknown Not
recorded
F Yes Yes
Cambodia BB16cat GJA8 Pediatric cataract Unknown – –
PP50cat MIP Pediatric cataract Unknown M – –
SR11cat Possibly PAX6 Pediatric cataract Unknown – –
SR12cat None segregating Pediatric cataract Unknown M – –
Sri Lanka PCC10-
189
Possibly GCNT2 Congenital cataract with nystagmus Birth Not
recorded
M No No
PCC01-
34
None predicted Pediatric cataract, no perception of light,
minor phthisis, left corneal scar
Birth 11 years M – –
PCC10-
188
EPHA2 or GCNT2 Pediatric cataract Birth Not
recorded
F Yes Yes
PCC01-
97A
Multiple; CRYBB1
most likely
Pediatric cataract, microphthalmos and
pseudophakia
Birth 6 years F Yes Yes
PCC02-
105
CRYGD Bilateral congenital cataract Unknown 7 years F No No
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BB16cat and PP50cat from Cambodia; PCC02-105 and
PCC10-188 from Sri Lanka) with a further four possibly
solved (E1 from Bhutan; SR11 from Cambodia; and
PCC01-97A and PCC10-189 from Sri Lanka). This equates
to a rate of 18% (6/33) of cataract patients from the region
having disease-causing mutations in known cataract-caus-
ing genes, and 30% if the possibly solved cases are
included. This is substantially lower than the rates of 60%–
70% reported in case series of European descent (Gillespie
et al., 2014; Javadiyan et al., 2017; Ma et al., 2016). This
difference remains evident even when compared with our
previous study of Australian patients screened using the
same gene panel, the same sequencing methodology, and
the same variant filtering criteria, which found a success
rate of 62% (Javadiyan et al., 2017). Gene discovery for
this disease has predominantly been undertaken in patients
of European descent and it is clear from this study that
there remain novel genes to discover for inherited pediatric
cataract in non-European populations. We can hypothesize
that such genes contribute to a higher proportion of disease
in these relatively understudied populations. Families with
multiple affected family members and clear phenotypes
such as SR12 will be important in identifying such genes.
Alternatively, it is possible that a portion of the patients
included in this study have nongenetic cataracts. The
recruitment strategies employed made it difficult to obtain
thorough family histories for all patients and in several
cases, the inclusion of a child was made at the discretion
of the examining clinician based on the information to
hand. Up to 25% of cataract is inherited (Shiels & Hejt-
mancik, 2007) and the rate may be lower in areas without
vaccination programs to prevent maternal rubella infection.
This may mean that more children with this, or other non-
genetic causes of cataract blindness, may have been inad-
vertently included in this study. Maternal rubella infection,
however, does not account for the observations in this
FIGURE 2 Segregating and likely causative variants in pediatric cataract patients and their families. The chromatograms show the variant
detected by Sanger sequencing in the proband and any available family members. The gene names and mutation at cDNA and protein level are given.
Solid circles indicate affected females and solid squares show the affected males. The arrowhead indicates the proband sequenced on the gene panel
by Ampliseq. * indicates DNA available for segregation analysis. Homozygous variants are indicated on the chromatogram by an arrow. (a) GJA8
variant in proband P1 and her sister; (b) GALE variant detected in patient E1; (c) compound heterozygous variants in GALK1 in proband WW1 not
present in unaffected brother. Variants confirmed by MassArray, no chromatogram available; (d) GJA8 variant in BB16cat; (e) MIP variant
segregates in family of proband PP50cat; (f) PAX6 variant in SR11cat; (g) no segregating variants detected in the family of SR12cat; (h)
Homozygous GCNT2 variant in family of PCC10-189; (i) HSF4 variant in patient PCC01-34 is likely benign; (j) Homozygous EPHA2 and GCNT2
variants in proband PCC10-188; (k) Deletion of codon 63 of CRYBB1 and novel missense mutation in PAX6 in patient PCC01-97A. Three other
possible causative variants also detected; (l) CRYGD single base deletion segregates in the family of proband PCC02-105
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study. In 2012, Sri Lanka had a national rubella vaccina-
tion program, but Cambodia and Bhutan did not (Centres
for Disease Control and Prevention, 2013). We found the
highest rate of causative mutations in Bhutan (two of five
probands). The audit also reported no cases of measles/
rubella induced vision loss in the Bhutanese school chil-
dren (Farmer et al., 2015). It remains to be determined
how many of the probands with no detected mutations in
this panel of genes have genetic forms of cataract and how
many may be accounted for by environmental causes.
This study has thoroughly evaluated a large number of
known cataract genes in a population which has not previ-
ously been studied to any extent, however, there are some
limitations. The coverage of the target genes in this gene
panel is high, but some regions could not be sequenced,
either due to the inability to design amplicons in a given
region, or the poor performance of some amplicons. A
detailed assessment of the coverage and quality of sequenc-
ing using this panel on the Ion Torrent PGM has been pub-
lished previously by our group (Javadiyan et al., 2017).
Furthermore, the bioinformatic analysis can have a pro-
found effect on the ability to detect variants. The algo-
rithms for sequence alignment, variant calling, and variant
annotation are constantly improving and these data should
be reanalyzed in the future to detect variants missed in the
current pipeline. The guidelines from the American College
of Medical Genetics and Genomics and the Association for
Molecular Pathology (Richards et al., 2015) classify most
of the detected variants as variants of uncertain signifi-
cance. This particular algorithm is designed to provide con-
servative findings in a clinical setting where results of
genetic testing will be returned to patients and clinicians
for use in the medical management of patients and genetic
counseling of families. This necessarily requires caution
when applying a label of pathogenic and only the highest
levels of evidence are accepted. This tool reminds us to
interpret the findings with caution and to seek additional
evidence regarding the pathogenicity of these variants, but
a classification of “uncertain significance” does not rule
out a variant from being the true cause of disease.
This study has identified novel genetic mutations linked to
pediatric cataract; p.(Pro280Arg) and p.(Leu7Pro) in GJA8,
p.(Thr160Argfs*8) in CRYGD, p.(Arg385Cys) in GCNT2,
p.(Ser330Phefs*51) in EPHA2, and very likely p.(Val62_-
Phe64del) in CRYBB1. This extends the known mutation
spectrum for pediatric cataract. We also identified a recurrent
mutation, p.(Arg33Cys) in MIP, segregating in a family from
Cambodia. This mutation was previously reported de novo in
a sporadic case of nonsyndromic bilateral congenital cataract
(Ma et al., 2016) and in a multigeneration Chinese family
with total congenital cataract (Gu et al., 2007).
Two novel variants were identified in the CRYGD gene
in a family from Sri Lanka. The first, a frameshift mutation,
p.(Thr160Argfs*8), clearly segregates with disease in the
family and is the most likely cause of the disease in this
family. The proband (PCC02-105) also carries a second
novel variant in this gene, which is also predicted to be
pathogenic, p.(Gly100Asp). This second variant is not pre-
sent in any of the other affected family members and thus is
not likely to be the primary cause of the disease. This high-
lights the need to treat the interpretation of variants identi-
fied in only one individual with extreme caution. In terms
of this study, this is applicable to patient BB16cat with a
mutation in GJA8 as well as the EPHA2 variant in Sri Lan-
kan proband PCC10-188 and the novel variants in PAX6
and CRYBB1 in PCC01-97A. The novel variants in EPHA2
and CRYBB1 are a frameshift and a deletion, respectively.
Both genes and types of mutations have a strong tendency
to be pathogenic for cataract; however, the CRYBB1 muta-
tion occurs in the context of other possibly pathogenic vari-
ants and additional evidence is required to determine if
these novel variants are in fact the cause of disease.
We further identified three genes with recessive muta-
tions in cataract patients. Proband WW1 from Bhutan is
compound heterozygous for two mutations in GALK1. His
unaffected brother does not carry either mutation. The par-
ents were not available for testing; thus, it is not defini-
tively determined if these variants are inherited in cis or
trans; however, recessive mutations in this gene have been
reported in many families with cataract previously, both as
homozygous and compound heterozygous variants (Shiels
et al., 2010). Both these variants are present at low rates in
the ExAC database, consistent with a recessive inheritance
pattern. The second recessive mutation identified in this
cohort is in GCNT2, which is well known to cause reces-
sive cataract (Shiels et al., 2010). The novel homozygous
variant, p.(Arg385Cys), was detected in two brothers from
Sri Lanka (PCC10-189 and his brother), as well as a third
affected child (PCC10-188), not reported to be related but
attending the same school for the blind. The presence of
this homozygous novel variant in two “families” from the
same school in Sri Lanka suggests that these two families
are consanguineously related but this cannot be definitively
determined from the data generated for this study. PCC10-
188 also carries a homozygous mutation in EPHA2
(p.(Ser330Phefs*51)). This gene has been reported with
this mode of inheritance in a family from Pakistan (Kaul
et al., 2010). This homozygous variant was not present in
ExAC at the time of generating the data; however, it has
subsequently been identified in two individuals in the gno-
mAD resource. The homozygosity in proband PCC10-188
further suggests the consanguinity of the parents of this
child, in addition to the GCNT2 variant. Either mutation is
likely sufficient to cause cataract in this child.
There has been just one report of association between
the deficiency of GALE and pediatric cataract in a 5.5-
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year-old girl with autosomal recessive pediatric cataract
(Schulpis et al., 1993). Here, we report a missense varia-
tion, p.(Arg256Gly), in this gene in a proband from Bhutan
with pediatric cataract, amblyopia, and retinal dystrophy
(patient E1). Without additional family members, we can-
not definitively determine a role for this variant in the dis-
ease; however, the variant has been reported at low
frequency in public databases and is predicted by at least
one algorithm to be benign. Coupled with the knowledge
that this gene has only been reported previously in reces-
sive disease, it seems unlikely that it is the sole cause of
cataract and associated features in this proband.
We were able to determine the genetic cause in approxi-
mately 21% of pediatric cataract cases screened from three
diverse Asian countries. It is probable that this mutation
rate would be improved by more complete ascertainment of
family members of affected probands. It is clear that while
the known cataract genes do contribute to this disease in
the Asian region and that novel variants exist in these pop-
ulations, there is a clear need for further research to
uncover the remaining genetic causes of the disease in this
and other understudied regions.
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